What is Most Important to Potential Participants Similarity of Patient Responses in Three Therapeutic Areas John Needham’s PatientQuest Surveys HIV >250 responses OAB >400 responses Psoriasis > 50 responses
Jul 11, 2015
What is Most Important to Potential Participants
Similarity of Patient Responses in Three Therapeutic Areas
John Needham’s PatientQuest Surveys
HIV >250 responsesOAB >400 responsesPsoriasis > 50 responses
2008 Clinical Research Educational Conference 2
22%
9% 12%
0%
9% 10% 12%13%
9%14% 10%
45%
9%
37%
19%
49%
11%9%
0%
25%
50%
75%
100%
0-3 Months 4-11 Months 1-2 Years 3-4 Years 4+ Years Diagnosed inthe Trial
Overall Life Threatening Chronic
Source: February 2005 Volunteer Survey
Percent of Respondents N= 534
How Long Did You Have Your Medical Condition How Long Did You Have Your Medical Condition Before You Participated in a Clinical Trial?Before You Participated in a Clinical Trial?
Recruitment Insights
3
From The Time You First Heard About The Clinical Trial, How Long Before You Decided To Participate?
40%
30%
16% 15%
48%
38%
9%5%
45%
36%
12% 8%
0%
25%
50%
75%
100%
Same Day 0-1 Week 2-3 Weeks 4 Weeks+
Overall Life Threatening Chronic
Source: February 2005 Volunteer Survey
Percent of Respondents N= 534
2008 Clinical Research Educational Conference 4
Which would most likely affect your decision to participate in a trial?
55
117
32
65
50
90
59
20
0
20
40
60
80
100
120
140
Study
Dur
ation
Possib
le Side E
ffects
Compe
nsati
on
Requir
ed Num
ber o
f Visi
ts
Free M
edica
tion
Distan
ce fr
om In
vesti
gatio
n Clin
ic
All of t
he A
bove
Other
Nu
mb
er o
f res
po
nse
s
0%10%20%30%40%50%60%70%80%90%100%
Responses
Percentage
HIV Patients
2008 Clinical Research Educational Conference 5
Over Active Bladder Patients
0 20 40 60 80 100 120 140 160
Possible side effects of the study medication
Possibility of receiving a placebo (sugar pill)
Taking the medication correctly
Birth control requirements
Getting to an appointment
Having to sit too long in the waiting room before being seen
Scheduling study appointments in my already busy schedule
Number of required study visits
Duration or how long the study will last
If this drug will do me any good
Driving distance to the study clinic
Other
2008 Clinical Research Educational Conference 6
Psoriasis PatientsDecision to participate in clinical trial
05
10152025303540
length of
stud
y
poss
ible sid
e effe
cts
compe
nsati
on
requ
ired n
umbe
r of v
isits
free m
edica
tion
distanc
e from st
udy c
linic
all of
the a
bove
other
7
Would you discuss trial participation with a partner, friend or family
member?
Yes, 183
No, 16
YesNo
2008 Clinical Research Educational Conference 8
If considering an OAB trial, who, other than the study doctor, would you discuss the
decision with?
0 20 40 60 80 100 120 140
Spouse or partner, and immediate family members
Urology specialist
A study nurse
Your family doctor (GP)
One of my friends
My gynecologist
A previous trial participant
Other
OAB US responders
2008 Clinical Research Educational Conference 9
PsoriasisWith whom besides your Doctor would you discuss
decision on trial participation?
05
10152025303540
immediate familymembers
special services therapist other
2008 Clinical Research Educational Conference 10
If considering a trial, who, other than the study doctor, would you discuss the decision with?
0 5 10 15 20 25 30 35
Spouse or partner, and immediate family members
Your specialist doctor (Urologist; OB/GYN)
A study nurse
Your family doctor (GP)
Friend / carer
Continence support group representative
A previous trial participant
Other
EU Results
2008 Clinical Research Educational Conference 11
Other than receiving a new medical treatment for OAB, what else would interest you in joining and
remaining in a clinical research study?
0 20 40 60 80 100 120 140
On-going discussions with a urology specialist
A trusted web site(s) for OAB information
Empathic listening to how OAB disrupts my life
Advice on how to get on with a normal active life
Exercises to strengthen my bladder
Recipes that help promote a healthy bladder
Prevention
Surgery or some other means of permanent cure
US Results
2008 Clinical Research Educational Conference 12
Other than receiving a new medical treatment for OAB, what else would interest you in joining and
remaining in a clinical research study?
0 5 10 15 20 25 30
On going discussions with a urology specialist
A trusted web site(s) for OAB information
Empathic listening to how OAB disrupts my life
Advice on how to get on with a normal active life
Exercises to strengthen my bladder
Recipes that help promote a healthier bladder
EU Results
2008 Clinical Research Educational Conference 13
11. Do you feel your regular doctor understands how you feel about having OAB?
0 20 40 60 80 100 120 140
Yes
No
31 31.5 32 32.5 33 33.5 34
Yes
No
Internet responses
Inner-city responses
2008 Clinical Research Educational Conference 14
Do you feel your regular doctor understands how you feel about having OAB?
0 5 10 15 20 25 30 35 40 45 50
Yes
No
EU Results
2008 Clinical Research Educational Conference 15
Can you or do you prefer to discuss your OAB with the nurses in your doctor’s office?
0 20 40 60 80 100 120 140
Yes
No
0 5 10 15 20 25 30 35 40
Yes
No
Internet responses
Inner-city responses
2008 Clinical Research Educational Conference 16
Can you or do you prefer to discuss your OAB with the nurses in your doctor’s office?
0 5 10 15 20 25 30 35 40
Yes
No
EU Results
2008 Clinical Research Educational Conference 17
Which of the following would keep you interested in participating in a study for a year or longer?
107 103 101 9986 83
0
20
40
60
80
100
120
Vouch
ers f
or tra
vel o
r parki
ng
Appoin
tmen
t rem
inder
not
ice
Oppor
tunit
y to m
eet ot
her p
artic
ipants
Printo
ut o
f upco
ming
appo
intm
ents
Feedba
ck ca
rds t
o co
mmen
t on
the
...
Mon
thly
newsle
tter
Nu
mb
er o
f R
esp
on
ses
0%10%20%30%40%50%60%70%80%90%100%
Responses
Percentage
HIV
18
Which of the following would keep you interested in participating in a study for 3 months or longer?
0 20 40 60 80 100 120 140 160 180 200
Free local or national support groupmembership
Opportunity to meet other participants involvedin the trial, in a group setting
"Thank you" letters after kept medicalappointments
Appointment reminder notice by mail or email
Telephone reminder prior to my nextappointment
Monthly newsletter containing OAB relatedinformation
"Appreciation items" when completingmilestones in the study (up to $50 total)
The hope of relief from my symptoms
Having access to my records the end of thestudy
Other
USA OAB Patients
2008 Clinical Research Educational Conference 19
Which of the following would keep you interested in participating in a study for 3 months or longer?
0 10 20 30 40 50 60
The possibility of relief from my symptoms
Regular access to a specialist doctor
Free local or national support group membership
Opportunity to meet other participants involved in the trial, in a group setting
Monthly newsletter containing OAB related information
Telephone reminder prior to my next appointment
Appointment reminder notice by mail or email
Vouchers for travel expenses and parking
Having access to my records and progress during the study
"Thank you" letters after kept medical appointments
"Appreciation items" when completing milestones in the study
Other
EU OAB Patients
2008 Clinical Research Educational Conference 20
What would keep you interested in a 3 month trial
05
101520253035
com
pens
ate
trave
l exp
ense
s
supp
ort g
roup
mem
bers
hip
mee
t oth
er p
artic
ipants
"than
k yo
u" le
tters
rem
inde
r not
ice
tele
phon
e re
min
der
mon
thly
newsle
tter
"app
recia
tion
item
s"
othe
r
Psoriasis Patients
21
Key Findings• Regardless of the condition, addressing
potential side effects with a potential participant is of paramount importance
• Participants need user friendly literature about the study to share with their family and their family doctor
• Participants want to talk with specialists or providers on an on-going basis if they are going to remain in a study
22
Participants have expectations:• travel / parking expenses provided • strong desire to meet other participants
• supportive website just for the study participants
• mechanism to tell their friends or support group members about the study
• progress reports through the course of the trial on how they are responding to the treatment
23
7 Take Away Messages• Assess the feasibility for every study• Whatever you or anyone thinks will work, it
must be tested and proven; budget for it• Develop a site Recruitment Training Continuum• Never underestimate the multiple forces exerted
on the patient’s mind set and their family’s motivation
5. Archive what you have learned6. You are in the business of delivering “Evaluable
Data”7. “Fish where the fish are”